Ga-68 NODAGA-exendin-4

N/A

Report date: 2025/11/20 11:38:32

NME

Base Information

Drug NameGa-68 NODAGA-exendin-4

Drug Alias Name68Ga-NODAGA-exendin-4 (type II diabetes)68Ga-NOTA-MI-exendin-4Gallium-68-NOTA-MI-exendin-4NOTA-MI-exendin-4-[68Ga]glucagon-like peptide-1 analog (radiolabelled-exendin, type 1 diabetes) +[7]

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agent +[5]

Mechanisms of ActionPositron-emission tomography enhancersRadionuclide imaging enhancersEmission-computed tomography enhancers

TargetsNot applicable

Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Insulinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesRadboud University Nijmegen

China Registration ClassN/A

Develop Information

Active CompaniesRadboud University Nijmegen

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Insulinoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A